Promega Corporation

SRE Reporter Assay for MAPK ERK Signaling via RTK and GPCR Scientific Poster

Share

SEARCH POSTERS

Abstract

Jey Cheng, Pete Stecha, Keith Wood and Frank Fan
Promega Corporation

Bioluminescent reporter assays are uniquely suited for high- throughput screening due to their inherently high sensitivity, wide dynamic range and low susceptibility to compound interference. Here, we have incorporated the technical advancement of luciferase reporter genes and vectors to build an improved serum response element (SRE) luciferase construct for MAPK/ERK signaling pathway. The large dynamic range of SRE luciferase reporter assay allows efficient screening for RTK inhibiitors for receptor tyrosine kinase pathway and also GPCR modulators for GPCR pathway. The Dual-Luciferase Reporter Assay System (Cat.# E1910), wherein the second plasmid expresses the target receptor of interest and Renilla lucifease as internal control, improves data quality by providing simultaneous monitoring of nonspecific effects such as cytotoxicity.

Document Icon Download the poster PDF (184kb)

  • Part# PS086
  • Printed in USA.

It appears that you have Javascript disabled. Our website requires Javascript to function correctly. For the best browsing experience, please enable Javascript.

Scientists at Your Service

Scientists at Your Service

We offer a range of services to help you succeed using Promega technologies. From product training to set up of automated systems and development of custom applications—our scientific support goes beyond the basics.

Ask us! We are here to help you.